-+ 0.00%
-+ 0.00%
-+ 0.00%

AC IMMUNE SA: INFORMED BY JANSSEN PHARMACEUTICALS THAT ENROLLMENT HAS BEEN TEMPORARILY PAUSED FOR PHASE 2B RETAIN TRIAL

Reuters·02/17/2026 21:39:48

Please log in to view news